Digital Mammography Market Size & Share 2025 - 2034

Digital Mammography Market Size

The global digital mammography market was valued at USD 1.7 billion in 2024 and is projected to grow from USD 1.9 billion in 2025 to USD 4.5 billion by 2034, expanding at a CAGR of 10.4%. The global market is experiencing significant growth, driven by the increasing prevalence of breast cancer worldwide, rising awareness about early detection, proactive government initiatives, and rapid advancements in technology.

Digital mammography, an advanced imaging technology, captures high-resolution images of breast tissue, enabling early detection and diagnosis of breast cancer. These systems are widely utilized in clinical settings, including hospitals, diagnostic centers, and specialty clinics. Prominent players in the market include Hologic, GE Healthcare, Siemens Healthineers, Fujifilm Holdings, and Koninklijke Philips. The market focuses on devices such as full field digital mammography (FFDM) and 3D tomosynthesis systems, which aim to improve diagnostic accuracy, reduce radiation exposure, and enhance patient outcomes.
 

The market expanded from USD 1.3 billion in 2021 to USD 1.6 billion in 2023. This growth is primarily attributed to the rising incidence of breast cancer and increasing awareness about early detection. The adoption of digital and AI-powered mammography systems has surged, supported by government screening programs and technological advancements. Additionally, the healthcare sector's shift toward patient-centric diagnostics has positioned digital mammography systems as the preferred choice, offering improved comfort, accuracy in imaging, reduced diagnostic errors, and an enhanced patient experience.
 

The growing prevalence of breast cancer is a key factor driving the digital mammography market, as early detection is critical for achieving better clinical outcomes. For example, in 2022, 2.3 million women were diagnosed with breast cancer, and 670,000 deaths were reported globally. These statistics underscore the urgent need for advanced diagnostic tools. Digital mammography systems, particularly those integrated with digital and AI capabilities, are increasingly adopted by hospitals and other end users worldwide to enhance screening capabilities.
 

Increasing awareness and emphasis on breast cancer screening programs have become pivotal in combating breast cancer. These efforts are further bolstered by government and health organization initiatives aimed at promoting early detection through the widespread adoption of digital mammography and AI-enhanced imaging technologies. For example, the CDC’s National Breast and Cervical Cancer Early Detection Program has facilitated breast and cervical screenings for over 6 million women. In regions with a high prevalence of breast cancer, such initiatives have implemented targeted strategies to encourage annual screenings, improve diagnostic accuracy, and reduce mortality rates. Consequently, the integration of digital mammography systems, particularly 3D tomosynthesis and AI-powered diagnostics, has become a cornerstone of these efforts, offering improved imaging precision and enhanced patient comfort.
 

Digital mammography is an advanced breast imaging technique that uses low-dose X-rays to produce high-resolution digital images of breast tissue, aiding in the early detection and diagnosis of breast cancer. Unlike traditional film-based mammography, digital systems allow images to be stored electronically, enhanced for better clarity, and easily shared among healthcare providers.
 

Digital Mammography Market Trends

• Digital mammography has become a cornerstone in modern healthcare, offering enhanced diagnostic accuracy and streamlined clinical workflows. With continuous technological advancements, these systems deliver high-resolution imaging, improved tissue differentiation, and faster processing times, providing significant advantages over traditional film-based methods and other imaging technologies.
   
• For example, Hologic’s 3Dimensions Digital Mammography System exemplifies innovation in breast imaging. It delivers fast, high-resolution 3D mammography exams using advanced detector technology and state-of-the-art 3D imaging capabilities. Designed to detect more invasive cancers with greater precision, the 3Dimensions platform supports comprehensive breast cancer screening, risk assessment, and workflow efficiency.
   
• Additionally, digital mammography systems are recognized for their rapid image acquisition and processing speeds, which are critical in high-volume screening environments. Enhanced ergonomic designs and patient-focused features further improve patient experiences, reducing discomfort and encouraging routine screenings.
   
• These technological advancements position digital mammography as an indispensable tool in breast health management. By offering faster, more accurate imaging and supporting early detection strategies, digital mammography remains the preferred choice for comprehensive breast cancer screening and diagnosis across various healthcare settings.
   

Digital Mammography Market Analysis

Based on the product type, the market is segmented into 2D full field digital mammography tomosynthesis and 3D full field digital mammography tomosynthesis. In 2024, the 2D full field digital mammography tomosynthesis segment dominated the market, holding the largest share due to its ability to support diverse imaging formats and advanced diagnostic tools. This segment was valued at USD 1.1 billion in 2024 and is projected to reach USD 2.9 billion by 2034, growing at a CAGR of 10.2%. The growth is attributed to the rising demand for integrated imaging solutions, AI-powered diagnostics, and comprehensive breast cancer screening programs across hospitals and diagnostic centers.
 

Meanwhile, the 3D full field digital mammography tomosynthesis segment is anticipated to reach a valuation of USD 1.6 billion by 2034, with a slightly higher CAGR of 10.6%. This growth is driven by advancements in imaging technologies, AI-driven image analysis, and automated workflow tools, which are increasingly preferred in both hospitals and diagnostic centers for their enhanced imaging capabilities and diagnostic accuracy.
 

• 2D full field digital mammography tomosynthesis is a critical tool in breast cancer diagnosis, offering high-resolution digital images that aid radiologists in detecting subtle abnormalities such as microcalcifications, small masses, and architectural distortions. Enhanced image clarity significantly improves the detection of early-stage breast cancer, enabling timely intervention and better patient outcomes.
   
• For example, Siemens Healthineers' MAMMOMAT Inspiration is a 2D full field digital mammography tomosynthesis system designed for low-dose imaging with high contrast sensitivity. It is widely used in routine breast cancer screening and diagnostic evaluations. The system features automated exposure control and an ergonomic design to enhance patient comfort.
   
• Moreover, this technology facilitates rapid image capture and processing, streamlining diagnostic workflows in clinical settings. Radiologists can review images more efficiently, reducing patient waiting times and increasing the number of screenings conducted daily. This efficiency is particularly advantageous in high-volume diagnostic centers.
   
• Additionally, 2D full field digital mammography tomosynthesis systems are cost-effective and widely accessible, making them ideal for national and regional breast cancer screening programs. Their affordability allows for broader implementation, especially in resource-constrained settings, without compromising diagnostic quality. These factors contribute significantly to the growth of this segment. 

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the digital mammography market is segmented into hospitals, specialty clinics, and diagnostic centers. The hospitals segment accounted for the highest market share of 48.5% in 2024.
 

• The hospital segment holds the largest market share due to the availability of advanced imaging infrastructure and the presence of skilled radiologists. Hospitals serve as primary centers for breast cancer screening, diagnosis, and treatment, driving the adoption of multimodal imaging systems and AI-integrated digital mammography technologies.
   
• Additionally, the growth of healthcare infrastructure, particularly in developing regions such as the Middle East, Africa, and Asia-Pacific, is accelerating the adoption of advanced digital mammography techniques, including 2D full-field digital mammography tomosynthesis and 3D full-field digital mammography tomosynthesis, within hospital settings.
   
• For example, the UK's Department of Health and Social Care allocated approximately USD 17.4 million (EUR 15 million) from its Official Development Assistance (ODA) budget to enhance healthcare infrastructure in countries like Kenya, Ghana, and Nigeria. This investment, spanning from 2022 to 2025, aims to improve healthcare facilities and expand the medical workforce in these African nations.
   
• Such investments in healthcare infrastructure are expected to drive the adoption of advanced digital mammography technologies in hospital environments.
   
• Furthermore, the diagnostic centers segment, which accounted for 35.7% of the market share in 2024, is experiencing rapid growth. This expansion is fueled by the rise of dedicated breast imaging centers and outpatient diagnostic facilities. These centers are increasingly adopting compact, standalone digital mammography systems that offer cost-efficiency, ease of use, and quick turnaround times.

North America dominated the global digital mammography market with the highest market share of 40.5% in 2024. The market is driven by the rising incidence of breast cancer and growing demand for diagnostic services. Further, the region has advanced healthcare infrastructure, and a growing focus on early and accurate diagnosis also supports market growth.
 

• The U.S. market was valued at USD 485.2 million and USD 528.1 million in 2021 and 2022, respectively. In 2024 the market size reached USD 630.5 million from USD 576.2 million in 2023.
   
• The growth is primarily driven by the increasing prevalence of breast cancer in the U.S., which is significantly contributing to the market's expansion.
   
• For example, data from the American Cancer Society indicates that breast cancer is the most commonly diagnosed cancer among women in the U.S., accounting for approximately 30% (or 1 in 3) of all new female cancer cases annually. By 2025, it is estimated that around 316,950 new cases of invasive breast cancer and 59,080 cases of ductal carcinoma in situ (DCIS), a non-invasive form, will be diagnosed.
   
• This rising prevalence highlights the critical need for advanced diagnostic tools, such as digital mammography systems, which play a vital role in accurate and timely detection. The growing demand for these systems is a key factor driving the expansion of the market in the U.S.
   

Europe digital mammography market accounted for USD 379.5 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• The rising prevalence of breast cancer in the region, combined with increasing government initiatives to improve healthcare infrastructure, is expected to drive market growth.
   
• Additionally, the presence of key market players in the region strengthens Europe’s position in the market. These companies are actively focusing on innovation by developing advanced solutions, further contributing to market expansion.
   

Germany digital mammography market is projected to experience steady growth between 2025 and 2034.
 

• The rising prevalence of breast cancer in Germany is significantly contributing to the growth of the market in the country. For example, according to Statista, in 2022, breast cancer had the highest incidence rate among females, recorded at 148 cases per 100,000 population.
   
• As breast cancer cases continue to rise, the demand for advanced diagnostic tools, such as digital mammography systems, is increasing. These systems are crucial for early detection, monitoring, and effective management of breast cancer, thereby driving substantial growth in the market in Germany.
   

The Asia Pacific region is projected to be valued at USD 465.6 million in 2025 and is expected to reach USD 1.2 billion by 2034.
 

• Countries such as China, India, and Japan are increasingly adopting advanced technologies, driven by the rising demand for innovative diagnostic solutions and improved access to healthcare services.
   
• Furthermore, the rapid expansion of hospitals and diagnostic centers, coupled with government initiatives aimed at enhancing diagnostic capabilities, is significantly contributing to the market's growth in the region.
   

Japan digital mammography market is poised to witness lucrative growth between 2025 – 2034.
 

• The aging population in the country is a significant growth driver, with 29.1% of the population aged 65 and older as of 2023, according to Statista. This demographic shift is fueling the demand for early detection and preventive healthcare, thereby increasing the adoption of digital and AI-powered mammography systems.
   
• Furthermore, government-led initiatives and public awareness campaigns are enhancing access to screening services, solidifying Japan's position as a prominent market in the Asia-Pacific imaging sector.
   

Brazil is experiencing significant growth in the digital mammography market, driven by its expanding adoption of chronic disease management.
 

• In Brazil, breast cancer remains the most commonly diagnosed cancer among women. According to data from the Global Cancer Observatory, approximately 66,280 new cases were reported in 2020, representing 29.7% of all cancer types and an incidence rate of 43.7 per 100,000 women. This increasing prevalence is driving the demand for advanced, non-invasive diagnostic solutions, including digital mammography systems such as 2D, 3D tomosynthesis, and AI-powered imaging technologies.
   
• Furthermore, heightened awareness of the importance of early detection and prevention, supported by public health initiatives and educational campaigns, is encouraging individuals to undergo regular health screenings. This trend is anticipated to significantly contribute to the growth of the market in the region.
   

The digital mammography market in Saudi Arabia is expected to experience significant and promising growth from 2025 to 2034.
 

• The government of Saudi Arabia is making substantial investments in healthcare infrastructure to integrate advanced medical devices, such as digital mammography systems, into hospital settings. This initiative aims to provide optimal care for individuals affected by breast cancer in the country.
   
• According to the Saudi Ministry of Health, in 2023, the government allocated approximately USD 50.4 billion for healthcare infrastructure and social development.
   
• These investments are expected to improve the accessibility and quality of medical services for the population, thereby driving market growth.
   

Digital Mammography Market Share

• The top five players, including Hologic, GE Healthcare, Siemens Healthineers, Koninklijke Philips, and Fujifilm Holdings, collectively accounted for 42.5% of the total market share. These companies maintain their leadership through technological advancements, AI integration, regulatory approvals, and strategic partnerships with healthcare organizations.
   
• Hologic leads the market with its 3Dimensions Mammography System, which delivers higher-quality 3D images for radiologists, a more comfortable mammography experience for patients, and improved workflow for technologists. This system stands out due to its efficiency, real-time collaboration tools, and ability to detect 20-65% more invasive breast cancers, making it a preferred choice for high-volume breast imaging centers.
   
• Companies in the market are adopting competitive pricing strategies to expand their presence, particularly in emerging economies where affordability is crucial for market penetration. Leading players are also addressing unmet needs by introducing advanced digital mammography systems designed for high-resolution imaging and enhanced patient comfort. For instance, manufacturers are developing systems with features such as tomosynthesis (3D mammography), automated breast density assessment, and ergonomic compression paddles to improve diagnostic accuracy and reduce patient discomfort. These innovations are especially vital in breast cancer screening programs and routine diagnostic workflows, where precision, reliability, and patient compliance are critical for effective outcomes.
   
• Emerging trends in the digital mammography market include the development of high-throughput imaging systems, the integration of AI-powered diagnostic tools for enhanced image interpretation, and the expansion of portable and mobile mammography units. These advancements are driven by the increasing demand for early breast cancer detection, personalized screening protocols, and the shift toward decentralized and community-based healthcare delivery.
   

Digital Mammography Market Companies

Few of the prominent players operating in the digital mammography industry include:
 

• Allengers
• Canon
• Carestream
• Fujifilm Holdings
• GE Healthcare
• Genoray
• Hologic
• IDETEC Medical Imaging
• IMS Giotto
• Koninklijke Philips
• Planmed
• Siemens Healthineers
• SINO MDT
• SternMed
• Trivitron Healthcare
• Vannin Healthcare
   
• Hologic

Hologic provides a comprehensive range of digital mammography solutions, including the Selenia Dimensions and 3D Mammography (tomosynthesis) systems. These products are designed to deliver exceptional image quality, enable early cancer detection, and enhance patient comfort during procedures.
 

• GE Healthcare

GE HealthCare Technologies leverages its extensive global workforce of over 51,000 employees to drive innovation in digital mammography. Its product portfolio includes the Senographe Pristina system, which focuses on patient-centered design and advanced imaging capabilities. GE’s dedication to precision health and AI integration enhances diagnostic workflows and supports personalized care delivery.
 

• Koninklijke Philips

Koninklijke Philips operates in over 100 countries, supported by a strong distribution network. Its digital mammography offerings, such as the MicroDose systems, prioritize low-dose radiation and high-resolution imaging. Philips’ focus on connected care and scalable solutions position it as a key player in supporting global breast cancer screening programs.
 

Digital Mammography Industry News:

• In January 2025, Siemens Healthineers announced the first U.S. installation of its Mammomat B.brilliant mammography system. This system incorporates advanced 3D image acquisition and reconstruction technology, along with features for full-field digital mammography, breast biopsy, and titanium contrast-enhanced imaging. This development highlights Siemens Healthineers’ dedication to innovation in breast imaging and strengthens its competitive position in the diagnostic imaging market.
   
• In December 2024, GE HealthCare introduced the Pristina Via mammography system, an enhancement of the Senographe Pristina platform. This system aims to improve screening experience for both technologists and patients. The launch underscores GE HealthCare’s leadership in women’s health imaging and bolsters its market presence through innovation and operational efficiency.
   
• In January 2019, Trivitron Healthcare unveiled its Felicia – Digital Mammography system at an event in Dubai. Equipped with a Cesium Iodide scintillator detector and a 77-micron pixel pitch, Felicia enables precise visualization of micro-calcifications, which are critical for early breast cancer detection. This launch reinforced Trivitron’s reputation for delivering advanced imaging technology and strengthened its position in the global diagnostic imaging market.
   

The digital mammography market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• 2D full field digital mammography tomosynthesis
• 3D full field digital mammography tomosynthesis

Market, By End Use

• Hospitals
• Specialty clinics
• Diagnostic centers

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE